Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: Drug susceptibility, outcome, and risk factors for hospital mortality

Chinese Medical Journal

Volumn 125, Issue 2, 2012, Pages 226-229

  Chen, Rong ^a   Yan, Zhong Qiang ^a   Feng, Dan ^a   Luo, Yan Ping ^a   Wang, Lei Li ^a   Shen, Ding Xia ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Bloodstream infection; Hospital mortality; Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BLOODSTREAM INFECTION; CHILD; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; TEACHING HOSPITAL;

ADULT; AGED; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 84862967411     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.02.012     Document Type: Article

References (27)

1. Karchmer AW. Nosocomial bloodstream infections: organisms, factors, and implications. Clin Infect Dis 2000; 31 Suppl 4: s139-s143.
2. Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009; 49: 1496-1504.
3. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
4. Johnson AP. Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother 2011; 66 Suppl 4: iv43-iv48.
5. Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP. Methicillin-resistant Staphylococcus aureus: the superbug. Int J Infect Dis 2010; 14 Suppl 4: s7-s11.
6. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26: 166-174.
7. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317.
8. Li DZ, Chen YS, Yang JP, Zhang W, Hu CP, Li JS, et al. Preliminary molecular epidemiology of the Staphylococcus aureus in lower respiratory tract infections: a multicenter study in China. Chin Med J 2011; 124: 687-692.
9. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485.
10. Xiao YH, Wang J, Li Y; MOH National Antimicrobial Resistance Investigation Net. Bacterial resistance surveillance in China: a report from Mohnarin 2004-2005. Eur J Clin Microbiol Infect Dis 2008; 27: 697-708.
11. Gastmeier P, Sohr D, Geffers C, Behnke M, Daschner F, Rüden H. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Infection 2005; 33: 50-55.
12. Libert M, Elkholti M, Massaut J, Karmali R, Mascart G, Cherifi S. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. J Hosp Infect 2008; 68: 17-24.
13. de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011; 55: 1598-1605.
14. Park SY, Son JS, Oh IH, Choi JM, Lee MS. Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores. Infection 2011; 39: 141-147.
15. Ponce-de-León A, Camacho-Ortiz A, Macías AE, Landín-Larios C, Villanueva-Walbey C, Trinidad-Guerrero D, et al. Epidemiology and clinical characteristics of Staphylococcus aureus bloodstream infections in a tertiary-care center in Mexico City: 2003-2007. Rev Invest Clin 2010; 62: 553-559.
16. Guilarde AO, Turchi MD, Martelli CM, Primo MG, de Abreu Batista LJ. Bacteremias at a teaching hospital: etiology, antimicrobial susceptibility pattern and risk factors for mortality. Rev Assoc Med Bras 2007; 53: 34-38.
17. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158: 182-189.
18. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteraemia involving methicillin-susceptible and methicillin resistant Staphylococcus aureus. Arch Intern Med 2002; 162: 2229-2235.
19. Yu YY, Wang H, Zhang SW, Wang BE. Inhibition of methicillin-resistant Staphylococcus aureus by the compound Qingre granules. Chin Med J 2010; 123: 1017-1020.
20. Wang Z, Cao B, Liu YM, Gu L, Wang C. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycinresistant enterococci in China: a hospital-based study. Chin Med J 2009; 122: 1283-1288.
21. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006; 42: 647-656.
22. Nazar JR, Lavados A, Daher O, Bischoff MC. Microbiological and epidemiological analysis, and clinical outcome of patients with bloodstream infection from an Esquel hospital in the period 2007-2009. Rev Argent Microbiol 2010; 42: 151-164.
23. Big C, Malani PN. Staphylococcus aureus bloodstream infections in older adults: clinical outcomes and risk factors for in-hospital mortality. J Am Geriatr Soc 2010; 58: 300-305.
24. Benfield T, Espersen F, Frimodt-Møller N, Jensen AG, Larsen AR, Pallesen LV, et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007; 13: 257-263.
25. Fätkenheuer G, Preuss M, Salzberger B, Schmeisser N, Cornely OA, Wisplinghoff H, et al. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2004; 23: 157-162.
26. Seifert H, Wisplinghoff H, Kaasch A, Achilles K, Langhorst A, Peyerl-Hoffmann G, et al. Epidemiology, course and prognosis of Staphylococcus aureus bacteremiae: preliminary results from the INSTINCT (Invasive Staphylococcus aureus Infection Cohort) cohort. Dtsch Med Wochenschr 2008; 133: 340-345.
27. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281.